Evotec SE, Samsara BioCapital, and KCK Ltd., have launched Autobahn Labs, a novel virtual incubator partnering with top academic and research institutions to catalyze early-stage drug discovery and development. Autobahn Labs has already unveiled a strategic collaboration with UCLA Technology Development Group to identify and advance promising areas of scientific research with potential for patient therapies.   “Autobahn Labs was created to be a catalyst for translational research, working ...